Literature DB >> 6776154

Intermittent heparin treatment does not induce hypercoagulability in haemodialysed patients.

F Pusineri, A Bini, L Mussoni, G Remuzzi, M B Donati.   

Abstract

Antithrombin-III (AT-III) and factor VIII coagulant (F VIII:C) and antigenic (F VIII:RA) activities have been studied in nine conservatively treated and 26 dialysed uraemic patients. AT-III levels were not significantly different from those of controls in either group. Among dialysed patients, those who had experienced thrombotic occlusions of the vascular accesses could not be distinguished from the remaining patients on the basis of their AT-III levels. Both F VIII:C and F VIII:RA were slightly higher than in controls in conservatively treated patients, but significantly higher in haemodialysed patients, especially in those who had never experienced thrombotic complications of the vascular accesses. No acute changes were observed in either the AT-III or F VIII:C/F VIII:RA ratio in five patients given heparin therapy during a dialytic session or in the interdialytic period. Thus repeated intermittent heparin treatment does not induce a hypercoagulable state in haemodialysed patients.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6776154      PMCID: PMC1146174          DOI: 10.1136/jcp.33.7.631

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  13 in total

1.  Suloctidil: a novel inhibitor of platelet aggregation in human beings.

Authors:  G de Gaetano; G Miragliotta; R Roncucci; J Lansen; G Lambelin
Journal:  Thromb Res       Date:  1976-03       Impact factor: 3.944

2.  The ratio of factor VIII-related antigen and factor VIII biological activity as an index of hypercoagulability and intravascular clotting.

Authors:  K W Denson
Journal:  Thromb Res       Date:  1977-01       Impact factor: 3.944

3.  Arteriovenous-shunt thrombosis. Prevention by sulfinpyrazone.

Authors:  A Kaegi; G F Pineo; A Shimizu; H Trivedi; J Hirsh; M Gent
Journal:  N Engl J Med       Date:  1974-02-07       Impact factor: 91.245

Review 4.  Bleeding in uremia.

Authors:  S F Rabiner
Journal:  Med Clin North Am       Date:  1972-01       Impact factor: 5.456

5.  Bleeding in renal failure: is von Willebrand factor implicated?

Authors:  G Remuzzi; M Livio; M C Roncaglioni; G Mecca; M B Donati; G de Gaetano
Journal:  Br Med J       Date:  1977-08-06

6.  Asbestosis.

Authors:  B Mann
Journal:  Lancet       Date:  1977-12-10       Impact factor: 79.321

7.  Heparin-induced decrease in circulating antithrombin-III.

Authors:  K W Denson; C W Redman
Journal:  Lancet       Date:  1977-11-12       Impact factor: 79.321

8.  Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies.

Authors:  C B Laurell
Journal:  Anal Biochem       Date:  1966-04       Impact factor: 3.365

9.  Metabolism of antithrombin III (heparin cofactor) in man: effects of venous thrombosis and of heparin administration.

Authors:  D Collen; J Schetz; F de Cock; E Holmer; M Verstraete
Journal:  Eur J Clin Invest       Date:  1977-02       Impact factor: 4.686

10.  Heparin-induced decrease in circulating antithrombin-III.

Authors:  E Marciniak; J P Gockerman
Journal:  Lancet       Date:  1977-09-17       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.